CNTX
NASDAQ · Pharmaceuticals
Context Therapeutics Inc
$0.48
-0.02 (-3.97%)
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Price Target
Analyst Price Target
+4,792.6% upside
Low Target
$16.27
Average Target
$23.68
High Target
$31.54
Current Price
$0.48
Current
$0.48
$0.48
Target
$23.68
$23.68
$16.27
$23.68 avg
$31.54
Scenario Analysis
Bear Case
$16.27
3,261.6%
Low target
Base Case
$23.68
+4,792.6%
Avg target
Bull Case
$31.54
+6,416.5%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$3.62
-86.6% from high
52-Week Low
$0.49
+-1.2% from low
Target vs 52W High
$23.68
+554.1% vs high
Next Earnings Report
Aug 12, 2026
1d
tomorrow
EPS Est: $-0.09
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| LLY | Strong Buy | 38 | 79% | $1,330.33 | +12.2% |
| RDY | Strong Sell | 45 | 31% | — | +0.0% |
| JNJ | Buy | 31 | 71% | $299.55 | +15.5% |
| MRK | Buy | 36 | 69% | $159.27 | +23.9% |
| PFE | Hold | 36 | 39% | $33.90 | +26.7% |
| BMY | Hold | 35 | 40% | $174.50 | +169.6% |
| RPRX | Strong Buy | 16 | 88% | $36.26 | -36.1% |
| ZTS | Hold | 24 | 54% | $209.87 | +188.8% |